| Affiliation auteurs | Affiliation ok |
| Titre | Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Randrian V., Adenis A., Desrame J., Barbier E., Di Fiore F., Lievre A., Dahan L., Laurent-Puig P., Mineur L., Breysacher G., Roquin G., Louafi S., Lopez A., Louvet C., Borg C., Metges J-P., Faroux R., Gaba L., Manfredi S., Tougeron D. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 30 |
| Date Published | OCT |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
